Key Highlights
- Jake Fitzgerald appointed CEO of PureTech Scientific LLC by Iron Path Capital.
- PureTech is a global leader in glycolic acid synthesis and technology.
- Fitzgerald’s leadership will drive innovation and growth in Life Sciences and Specialty Chemicals.
Source: Business Wire
Notable Quotes
- “Jake’s keen understanding of market trends and visionary leadership are exactly what PureTech needs to continue its trajectory of success. We are confident that under his stewardship, Jake will empower the PureTech team to drive further innovation, create significant value for customers, and exceed our ambitious goals of setting new standards in our field.” — Scott Mraz, Co-founder and Managing Partner at Iron Path
- “I look forward to leading the talented team here to drive growth and continue pushing the boundaries of what’s possible to achieve the company’s full potential in this next chapter.” — Jake Fitzgerald, Chief Executive Officer (CEO) at PureTech Scientific LLC
SoHC's Take
Jake Fitzgerald’s appointment as CEO of PureTech Scientific marks a strategic move by Iron Path Capital to solidify its investment in the burgeoning glycolic acid market. Fitzgerald’s extensive industry experience and proven track record at Essentra and Dow Chemical make him well-suited to lead PureTech into its next phase of innovation and growth. His leadership is expected to enhance PureTech’s position as a leading supplier in the Life Sciences and Specialty Chemical industries, ensuring the company continues to set new benchmarks in ultra-high purity alpha hydroxy acids.
